Precision BioSciences Ownership | Who Owns Precision BioSciences?
Precision BioSciences Ownership Summary
Precision BioSciences is owned by 30.52% institutional investors, and 69.48% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.28% of its assets in Precision BioSciences shares.
DTIL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Precision BioSciences | 30.52% | - | 69.48% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2023 | 63 | -16.00% | 35,146,004 | 1.40% | 30 | 3.31% | 29 | -14.71% | 9 | -40.00% |
Sep 30, 2023 | 75 | -2.60% | 34,661,024 | -20.71% | 30 | 1.97% | 34 | 54.55% | 15 | -44.44% |
Jun 30, 2023 | 77 | -9.41% | 43,711,686 | -9.65% | 39 | 2.08% | 22 | -33.33% | 27 | 3.85% |
Mar 31, 2023 | 85 | -16.67% | 48,381,795 | -5.68% | 43 | 2.03% | 33 | -19.51% | 26 | -27.78% |
Dec 31, 2022 | 102 | 6.25% | 51,298,029 | -0.90% | 46 | 2.12% | 41 | -12.77% | 36 | 38.46% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 174.93K | 2.28% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 39.95K | 0.52% | - |
Fidelity Extended Market Index | 35.65K | 0.49% | 1.74K |
Galileo - Biotech Innovation Fund S USD | 28.81K | 0.40% | - |
Jacob Discovery Fd Instl | 20.09K | 0.26% | 5.00K |
Vanguard Strategic Small-Cap Equity Inv | 16.69K | 0.23% | - |
Vanguard VIF Small Co Gr | 15.40K | 0.21% | - |
iShares Micro-Cap ETF | 14.62K | 0.19% | - |
Fidelity Total Market Index | 11.52K | 0.16% | 6.49K |
Vanguard Explorer Inv | 11.41K | 0.16% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 21, 2024 | Kelly John Alexander | Chief Financial Officer | Buy | $20.28K |
Nov 04, 2024 | Scimeca Dario | General Counsel and Secretary | Sell | $4.82K |
Nov 04, 2024 | Amoroso Michael | President and CEO | Sell | $24.67K |
Jun 10, 2024 | Scimeca Dario | General Counsel and Secretary | Sell | $1.10K |
Jun 10, 2024 | SMITH J. JEFFERSON | Chief Research Officer | Sell | $589.50 |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | 1 | 2 |
2024 Q3 | - | - |
2024 Q2 | - | 8 |
2024 Q1 | - | 4 |
2023 Q4 | - | 2 |
DTIL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools